| Rosiglitazone in the treatment of type 2 diabetes mellitus: a critical review JM Malinowski, S Bolesta Clinical therapeutics 22 (10), 1151-1168, 2000 | 211 | 2000 |
| Outcomes of patients with coronavirus disease 2019 receiving organ support therapies: the international viral infection and respiratory illness universal study registry JP Domecq, A Lal, CR Sheldrick, VK Kumar, K Boman, S Bolesta, ... Critical care medicine 49 (3), 437-448, 2021 | 116 | 2021 |
| Interprofessional education among student health professionals using human patient simulation S Bolesta, JV Chmil American Journal of Pharmaceutical Education 78 (5), 94, 2014 | 110 | 2014 |
| Position paper on critical care pharmacy services: 2020 update I Lat, C Paciullo, MJ Daley, R MacLaren, S Bolesta, J McCann, ... Critical care medicine 48 (9), e813-e834, 2020 | 88 | 2020 |
| Hepatotoxicity associated with chronic acetaminophen administration in patients without risk factors S Bolesta, SL Haber Annals of Pharmacotherapy 36 (2), 331-333, 2002 | 87 | 2002 |
| The viral infection and respiratory illness universal study (VIRUS): an international registry of coronavirus 2019-related critical illness AJ Walkey, VK Kumar, MO Harhay, S Bolesta, V Bansal, O Gajic, ... Critical care explorations 2 (4), e0113, 2020 | 83 | 2020 |
| Guiding principles for the conduct of observational critical care research for coronavirus disease 2019 pandemics and beyond: The Society of Critical Care Medicine Discovery … AJ Walkey, RC Sheldrick, R Kashyap, VK Kumar, K Boman, S Bolesta, ... Critical care medicine 48 (11), e1038-e1044, 2020 | 49 | 2020 |
| An opinion paper outlining recommendations for training, credentialing, and documenting and justifying critical care pharmacy services W Dager, S Bolesta, G Brophy, K Dell, A Gerlach, J Kristeller, S Micek, ... Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 31 (8 …, 2011 | 49 | 2011 |
| Drug class combination–associated acute kidney injury RM Rivosecchi, JA Kellum, JF Dasta, MJ Armahizer, S Bolesta, ... Annals of Pharmacotherapy 50 (11), 953-972, 2016 | 44 | 2016 |
| Pharmacist instruction of physical assessment for pharmacy students S Bolesta, DP Trombetta, DS Longyhore American Journal of Pharmaceutical Education 75 (2), 29, 2011 | 35 | 2011 |
| Perceived motivating factors and barriers for the completion of postgraduate training among American pharmacy students prior to beginning advanced pharmacy practice experiences DA Hammond, DR Oyler, JW Devlin, JT Painter, S Bolesta, JM Swanson, ... American journal of pharmaceutical education 81 (5), 90, 2017 | 29 | 2017 |
| Preoperative statins and acute kidney injury after cardiac surgery: utilization of a consensus definition of acute kidney injury S Bolesta, LM Uhrin, JR Guzek Annals of Pharmacotherapy 45 (1), 23-30, 2011 | 26 | 2011 |
| Society of critical care medicine discovery viral infection and respiratory illness universal study (VIRUS): COVID-19 Registry Investigator Group. Outcomes of patients with … JP Domecq, A Lal, CR Sheldrick, VK Kumar, K Boman, S Bolesta, ... Crit Care Med 49 (3), 437-448, 2021 | 25 | 2021 |
| Severe acute respiratory syndrome–associated coronavirus 2 infection and organ dysfunction in the ICU: Opportunities for translational research PA Verhoef, S Kannan, JL Sturgill, EW Tucker, PE Morris, AC Miller, ... Critical care explorations 3 (3), e0374, 2021 | 21 | 2021 |
| Position paper on critical care pharmacy services (executive summary): 2020 update I Lat, C Paciullo, MJ Daley, R MacLaren, S Bolesta, J McCann, ... American Journal of Health-System Pharmacy 77 (19), 1619-1624, 2020 | 18 | 2020 |
| Elevated hepatic transaminases associated with telithromycin therapy: a case report and literature review S Bolesta, BP Roslund American Journal of Health-System Pharmacy 65 (1), 37-41, 2008 | 16 | 2008 |
| Hospital variation in management and outcomes of acute respiratory distress syndrome due to COVID-19 SW Johnson, MA Garcia, EKQ Sisson, CR Sheldrick, VK Kumar, K Boman, ... Critical care explorations 4 (2), e0638, 2022 | 14 | 2022 |
| Effect of sodium nitroprusside on the occurrence of atrial fibrillation after cardiothoracic surgery S Bolesta, TD Aungst, F Kong Annals of Pharmacotherapy 46 (6), 785-792, 2012 | 12 | 2012 |
| Possible Lenalidomide‐Induced Stevens‐Johnson Syndrome During Treatment for Multiple Myeloma PK Boruah, S Bolesta, SM Shetty Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 31 (9 …, 2011 | 12 | 2011 |
| Development and application of quality measures of clinical pharmacist services provided in inpatient/acute care settings NM Acquisto, CJ Beavers, S Bolesta, MS Buckley, KF Dobbins, CK Finch, ... Journal of the American College of Clinical Pharmacy 4 (12), 1601-1617, 2021 | 11 | 2021 |
